Novel Oral Anticoagulant Use Among Patients with Atrial Fibrillation Hospitalized with Ischemic Stroke or Transient Ischemic Attack

BACKGROUND: Novel oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for preventing stroke or transient ischemic attack (TIA) in patients with atrial fibrillation (AF), yet diffusion of these therapies and patterns of use among AF patients with ischemic stroke and TIA hav...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circ Cardiovasc Qual Outcomes
Auteurs principaux: Patel, Priyesh A., Zhao, Xin, Fonarow, Gregg C., Lytle, Barbara L., Smith, Eric E., Xian, Ying, Bhatt, Deepak L., Peterson, Eric D., Schwamm, Lee H., Hernandez, Adrian F.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512906/
https://ncbi.nlm.nih.gov/pubmed/26058721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.114.000907
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires